MediGene
Official site for Medigene. Medigene concentrates on the development of personalized T cell immunotherapies with a focus on haematological malignancies..
Enterprise value
($10m)
Share price
€0.13 MDG1.DE
Company register number
HRB 115761 (München)
Recent deals
Authorizing premium user...